Clinical Trial Update: An Enhanced Adherence Support Programme for Highly Active Antiretroviral Therapy (HAART) [Phase 3]

View source ↗

Summary

Phase 3 trial completed evaluating an enhanced adherence support program for people on highly active antiretroviral therapy (HAART) in HIV infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Snippet

Sponsor: Centre for the AIDS Programme of Research in South Africa | Conditions: HIV Infections | Phase 3 | Status: COMPLETED